At Stryker, compliance is an essential part of who we are and how we do business. We pride ourselves in doing the right thing and doing things right for our patients, customers and employees. Stryker’s Compliance Committees and Compliance Officers are responsible for helping us live up to our commitment to compliance.
At Stryker, we have long been committed to conducting our affairs in compliance with all applicable laws and regulations, and in accordance with the highest ethical standards. Each of us makes choices every day that contribute to the character of the Company. By making ethical decisions, we deal fairly with our customers, our suppliers, our shareholders and with each other.
All Stryker employees make the personal commitment to act with unquestionable integrity and honor, and in full compliance with the ethical and legal standards set out in our Code of Conduct.
Latest Press Releases
rssTransform: The Arguments for the function are not right.
currently rss feed file is , xsl file is http://www.stryker.com/files/xsl/trsnfeed.xsl
Business Review West Michigan presented Stryker with a “Deals of the Year” award in the “Mergers and Acquisitions” category for the acquisition of Boston Scientific’s Neurovascular division. Stryker was also honored as a finalist in the “Commercial Real Estate” category for the work on the lease of our new building on Romence Road in Portage, MI.
Stryker was named a World’s Most Innovative Company by Forbes Magazine, placing #95 out of 100 in the debut year of the list being published.
The editors of R&D Magazine announced the winners of the 49th Annual R&D 100 Awards, which salute the 100 most technologically significant products introduced into the marketplace over the past year. Stryker’s ADM X3 Mobile Bearing Hip Acetabular System was honored in the Life Sciences category.
FORTUNE Magazine named Stryker # 3 on the "World's Most Admired" list for companies in the "Medical and Other Precision Equipment" industry.
Stryker is now #323 on FORTUNE magazine’s list of top 500 U.S. companies in terms of revenue.